MIF and Sepsis: The present study demonstrates that proinflammatory/~oxidative (Macrophage Migration Inhibitory Factor, MIF) as well as anti-inflammatory/~oxidative (Human Thioredoxin-1, TRX1) agents are significantly raised in patients with severe sepsis and septic shock.